{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:37:13Z","timestamp":1792427833513,"version":"4.5.0"},"publisher-location":"Singapore","reference-count":174,"publisher":"Springer Nature Singapore","isbn-type":[{"value":"9789811973758","type":"print"},{"value":"9789811973765","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-981-19-7376-5_18","type":"book-chapter","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T17:03:57Z","timestamp":1679504637000},"page":"407-434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effects of Current Psychotropic Drugs on Inflammation and Immune System"],"prefix":"10.1007","author":[{"given":"Shvetank","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arghya Kusum","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malay Kumar","family":"Samanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Suttee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"issue":"4","key":"18_CR1","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/JCP.0000000000000341","volume":"35","author":"SN Ghaemi","year":"2015","unstructured":"Ghaemi SN. A new nomenclature for psychotropic drugs. J Clin Psychopharmacol. 2015;35(4):428\u201333.","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"18_CR2","first-page":"106","volume":"34","author":"CF Valenzuela","year":"2011","unstructured":"Valenzuela CF, Puglia MP, Zucca S. Focus on: neurotransmitter systems. Alcohol Res Health. 2011;34(1):106\u201320.","journal-title":"Alcohol Res Health"},{"issue":"1","key":"18_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/npp.2011.205","volume":"37","author":"E Haroon","year":"2012","unstructured":"Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology. 2012;37(1):137\u201362.","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"18_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/da.22084","volume":"30","author":"AH Miller","year":"2013","unstructured":"Miller AH, Haroon E, Raison CL, Felger JC. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety. 2013;30(4):297\u2013306.","journal-title":"Depress Anxiety"},{"key":"18_CR5","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.3389\/fnins.2019.01196","volume":"13","author":"S Westfall","year":"2019","unstructured":"Westfall S, Pasinetti GM. The gut microbiota links dietary polyphenols with management of psychiatric mood disorders. Front Neurosci. 2019;13:1196.","journal-title":"Front Neurosci"},{"issue":"3","key":"18_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/cei.13334","volume":"197","author":"FC Bennett","year":"2019","unstructured":"Bennett FC, Molofsky AV. The immune system and psychiatric disease: a basic science perspective. Clin Exp Immunol. 2019;197(3):294\u2013307.","journal-title":"Clin Exp Immunol"},{"key":"18_CR7","unstructured":"WHO Website. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression. Accessed 10 Oct 2021."},{"key":"18_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/pcn.12604","volume":"72","author":"S Boku","year":"2018","unstructured":"Boku S, Nakagawa S, Toda H, Hishimoto A. Neural basis of major depressive disorder: beyond monoamine hypothesis. Psychiatry Clin Neurosci. 2018;72:3\u201312.","journal-title":"Psychiatry Clin Neurosci"},{"key":"18_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1055\/s-2007-979535","volume":"29","author":"GR Heninger","year":"1996","unstructured":"Heninger GR, Delgado PL, Charney DS. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry. 1996;29:2\u201311.","journal-title":"Pharmacopsychiatry"},{"issue":"10","key":"18_CR10","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.biopsych.2016.05.005","volume":"81","author":"MS Lener","year":"2017","unstructured":"Lener MS, Niciu MJ, Ballard ED, Park M, Park LT, Nugent AC, Zarate CA Jr. Glutamate and gamma-aminobutyric acid Systems in the Pathophysiology of major depression and antidepressant response to ketamine. Biol Psychiatry. 2017;81(10):886\u201397.","journal-title":"Biol Psychiatry"},{"key":"18_CR11","doi-asserted-by":"publisher","first-page":"6871089","DOI":"10.1155\/2017\/6871089","volume":"2017","author":"W Liu","year":"2017","unstructured":"Liu W, Ge T, Leng Y, Pan Z, Fan J, Yang W, Cui R. The role of neural plasticity in depression: from hippocampus to prefrontal cortex. Neural Plast. 2017;2017:6871089.","journal-title":"Neural Plast"},{"key":"18_CR12","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fpsyt.2018.00334","volume":"9","author":"M Shadrina","year":"2018","unstructured":"Shadrina M, Bondarenko EA, Slominsky PA. Genetics factors in major depression disease. Front Psych. 2018;9:334.","journal-title":"Front Psych"},{"key":"18_CR13","doi-asserted-by":"publisher","first-page":"5890","DOI":"10.2174\/138161212803523554","volume":"18","author":"TM Michel","year":"2012","unstructured":"Michel TM, P\u00fclschen D, Thome J. The role of oxidative stress in depressive disorders. Curr Pharm Des. 2012;18:5890\u20139.","journal-title":"Curr Pharm Des"},{"issue":"6","key":"18_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11920-011-0232-0","volume":"13","author":"CL Raison","year":"2011","unstructured":"Raison CL, Miller AH. Is depression an inflammatory disorder? Curr Psychiatry Rep. 2011;13(6):467\u201375.","journal-title":"Curr Psychiatry Rep"},{"key":"18_CR15","unstructured":"https:\/\/www.medicalnewstoday.com\/articles\/anxiety-and-inflammation-is-there-a-link. Accessed 15 Oct 2021."},{"issue":"23","key":"18_CR16","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","volume":"289","author":"RC Kessler","year":"2003","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095\u2013105.","journal-title":"JAMA"},{"key":"18_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/da.1020","volume":"13","author":"RM Carter","year":"2001","unstructured":"Carter RM, Wittchen HU, Pfister H, Kessler RC. One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety. 2001;13:78\u201388.","journal-title":"Depress Anxiety"},{"issue":"Suppl 1","key":"18_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","volume":"12","author":"KJ Ressler","year":"2000","unstructured":"Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety. 2000;12(Suppl 1):2\u201319.","journal-title":"Depress Anxiety"},{"key":"18_CR19","first-page":"165","volume":"11","author":"P Nuss","year":"2015","unstructured":"Nuss P. Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatr Dis Treat. 2015;11:165\u201375.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"9","key":"18_CR20","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2174\/1570159X18666201015155816","volume":"19","author":"S Bhatt","year":"2021","unstructured":"Bhatt S, Devadoss T, Manjula SN, Rajangam J. 5-HT3 receptor antagonism a potential therapeutic approach for the treatment of depression and other disorders. Curr Neuropharmacol. 2021;19(9):1545\u201359.","journal-title":"Curr Neuropharmacol"},{"key":"18_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/npp.2016.198","volume":"42","author":"A Danese","year":"2017","unstructured":"Danese A, Lewis J. Psychoneuroimmunology of early-life stress: the hidden wounds of childhood trauma? Neuropsychopharmacology. 2017;42:99\u2013114.","journal-title":"Neuropsychopharmacology"},{"key":"18_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-398314-5.00001-5","volume":"88","author":"S Salim","year":"2012","unstructured":"Salim S, Chugh G, Asghar M. Inflammation in anxiety. Adv Protein Chem Struct Biol. 2012;88:1\u201325.","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"2","key":"18_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.31887\/DCNS.2017.19.2\/bbandelow","volume":"19","author":"B Bandelow","year":"2017","unstructured":"Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues Clin Neurosci. 2017;19(2):93\u2013107.","journal-title":"Dialogues Clin Neurosci"},{"issue":"9","key":"18_CR24","first-page":"617","volume":"91","author":"AB Locke","year":"2015","unstructured":"Locke AB, Kirst N, Shultz CG. Diagnosis and management of generalized anxiety disorder and panic disorder in adults. Am Fam Physician. 2015;91(9):617\u201324.","journal-title":"Am Fam Physician"},{"issue":"3","key":"18_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/da.22854","volume":"36","author":"E Jakubovski","year":"2019","unstructured":"Jakubovski E, Johnson JA, Nasir M, M\u00fcller-Vahl K, Bloch MH. Systematic review and meta-analysis: dose-response curve of SSRIs and SNRIs in anxiety disorders. Depress Anxiety. 2019;36(3):198\u2013212.","journal-title":"Depress Anxiety"},{"key":"18_CR26","first-page":"1134","volume":"25","author":"A Alzheimer","year":"1906","unstructured":"Alzheimer A. Ueber einen eigenartigen schweren Erkrankungsprozess der Hirnrinde. Neurol Central. 1906;25:1134.","journal-title":"Neurol Central"},{"issue":"4","key":"18_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1750-3639.1991.tb00666.x","volume":"1","author":"A Probst","year":"1991","unstructured":"Probst A, Langui D, Ulrich J. Alzheimer's disease: a description of the structural lesions. Brain Pathol. 1991;1(4):229\u201339.","journal-title":"Brain Pathol"},{"key":"18_CR28","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1194637","volume":"330","author":"F Ginhoux","year":"2010","unstructured":"Ginhoux F, Greter M, Leboeuf M, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330:841\u20135.","journal-title":"Science"},{"key":"18_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239\u201359.","journal-title":"Acta Neuropathol"},{"key":"18_CR30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14:463\u201377.","journal-title":"Nat Rev Immunol"},{"issue":"13","key":"18_CR31","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1016\/j.febslet.2013.05.026","volume":"587","author":"SA Shariati","year":"2013","unstructured":"Shariati SA, De SB. Redundancy and divergence in the amyloid precursor protein family. FEBS Lett. 2013;587(13):2036\u201345.","journal-title":"FEBS Lett"},{"issue":"2","key":"18_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/biof.1714","volume":"47","author":"A Delgado","year":"2021","unstructured":"Delgado A, Cholevas C, Theoharides TC. Neuroinflammation in Alzheimer's disease and beneficial action of luteolin. Biofactors. 2021;47(2):207\u201317.","journal-title":"Biofactors"},{"key":"18_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.brainresbull.2016.08.009","volume":"133","author":"HM Wilkins","year":"2017","unstructured":"Wilkins HM, Swerdlow RH. Amyloid precursor protein processing and bioenergetics. Brain Res Bull. 2017;133:71\u20139.","journal-title":"Brain Res Bull"},{"issue":"Suppl 2","key":"18_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/jnc.13632","volume":"139","author":"E Karran","year":"2016","unstructured":"Karran E, De SB. The amyloid cascade hypothesis: are we poised for success or failure? J Neurochem. 2016;139(Suppl 2):237\u201352.","journal-title":"J Neurochem"},{"issue":"5","key":"18_CR35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/NEN.0b013e318217a118","volume":"70","author":"B Rocha-Souto","year":"2011","unstructured":"Rocha-Souto B, Scotton TC, Coma M, et al. Brain oligomeric beta-amyloid but not total amyloid plaque burden correlates with neuronal loss and astrocyte inflammatory response in amyloid precursor protein\/tau transgenic mice. J Neuropathol Exp Neurol. 2011;70(5):360\u201376.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"23","key":"18_CR36","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.2174\/092986708785909111","volume":"15","author":"CX Gong","year":"2008","unstructured":"Gong CX, Iqbal K. Hyperphosphorylation of microtubule associated protein tau: a promising therapeutic target for Alzheimer disease. Curr Med Chem. 2008;15(23):2321\u20138.","journal-title":"Curr Med Chem"},{"issue":"3","key":"18_CR37","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1083\/jcb.143.3.777","volume":"143","author":"A Ebneth","year":"1998","unstructured":"Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow E. Overexpression of tau protein inhibits kinesindependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J Cell Biol. 1998;143(3):777\u201394.","journal-title":"J Cell Biol"},{"issue":"5","key":"18_CR38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","volume":"133","author":"T Guo","year":"2017","unstructured":"Guo T, Noble W, Hanger DP. Roles of tau protein in health and disease. Acta Neuropathol. 2017;133(5):665\u2013704.","journal-title":"Acta Neuropathol"},{"key":"18_CR39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1073\/pnas.94.1.298","volume":"94","author":"AD Alonso","year":"1997","unstructured":"Alonso AD, Grundke-Iqbal I, Barra HS, Iqbal K. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci U S A. 1997;94:298\u2013303.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18_CR40","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/156720510793611592","volume":"7","author":"K Iqbal","year":"2010","unstructured":"Iqbal K, Liu F, Gong C-X, Grundke-Iqbal I. Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res. 2010;7:656\u201364.","journal-title":"Curr Alzheimer Res"},{"key":"18_CR41","doi-asserted-by":"publisher","first-page":"24374","DOI":"10.1016\/S0021-9258(20)80536-5","volume":"268","author":"E K\u00f6pke","year":"1993","unstructured":"K\u00f6pke E, Tung YC, Shaikh S, Alonso AC, Iqbal K, Grundke-Iqbal I. Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem. 1993;268:24374\u201384.","journal-title":"J Biol Chem"},{"key":"18_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4161\/pri.1.1.4055","volume":"1","author":"G Lippens","year":"2007","unstructured":"Lippens G, Sillen A, Landrieu I, Amniai L, Sibille N, Barbier P, et al. Tau aggregation in Alzheimer\u2019s disease. Prion. 2007;1:21\u20135.","journal-title":"Prion"},{"key":"18_CR43","doi-asserted-by":"crossref","unstructured":"Simi G, Babi Leko M, Wray S, Harrington C, Delalle I, Jovanov-Milo\u0161evi\u0107 N, et al. Tau protein hyperphosphorylation and aggregation in Alzheimer\u2019s disease and other tauopathies, and possible neuroprotective strategies. Biomol Ther. 2016;6, 6","DOI":"10.3390\/biom6010006"},{"issue":"5054","key":"18_CR44","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u20135.","journal-title":"Science"},{"issue":"4","key":"18_CR45","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00005072-199704000-00001","volume":"56","author":"DW Dickson","year":"1997","unstructured":"Dickson DW. The pathogenesis of senile plaques. J Neuropathol Exp Neurol. 1997;56(4):321\u201339.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6738 Suppl","key":"18_CR46","doi-asserted-by":"publisher","first-page":"A23","DOI":"10.1038\/399a023","volume":"399","author":"DJ Selkoe","year":"1999","unstructured":"Selkoe DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature. 1999;399(6738 Suppl):A23\u201331.","journal-title":"Nature"},{"issue":"3","key":"18_CR47","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","volume":"155","author":"LF Lue","year":"1999","unstructured":"Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol. 1999;155(3):853\u201362.","journal-title":"Am J Pathol"},{"issue":"2","key":"18_CR48","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1006\/exnr.1999.7085","volume":"158","author":"J Wang","year":"1999","unstructured":"Wang J, Dickson DW, Trojanowski JQ, Lee VM. The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging. Exp Neurol. 1999;158(2):328\u201337.","journal-title":"Exp Neurol"},{"issue":"4","key":"18_CR49","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa1705971","volume":"378","author":"LS Honig","year":"2018","unstructured":"Honig LS, Vellas B, Woodward M, Boada M, Bullock R, Borrie M, et al. Trial of solanezumab for mild dementia due to Alzheimer's disease. N Engl J Med. 2018;378(4):321\u201330.","journal-title":"N Engl J Med"},{"issue":"7","key":"18_CR50","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41582-019-0205-1","volume":"15","author":"DJ Selkoe","year":"2019","unstructured":"Selkoe DJ. Alzheimer disease and aducanumab: adjusting our approach. Nat Rev Neurol. 2019;15(7):365\u20136.","journal-title":"Nat Rev Neurol"},{"key":"18_CR51","first-page":"135","volume":"2","author":"GP Morris","year":"2014","unstructured":"Morris GP, Clark IA, Vissel B. Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease. Acta Neuropathol Commun. 2014;2:135.","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"18_CR52","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015;16(6):358\u201372.","journal-title":"Nat Rev Neurosci"},{"key":"18_CR53","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer's disease. Alzheimers Dement (N Y). 2018;4:575\u201390.","journal-title":"Alzheimers Dement (N Y)"},{"key":"18_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.50","volume":"2","author":"CJ Garwood","year":"2011","unstructured":"Garwood CJ, Pooler AM, Atherton J, Hanger DP, Noble W. Astrocytes are important mediators of ab-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis. 2011;2:e167.","journal-title":"Cell Death Dis"},{"key":"18_CR55","doi-asserted-by":"publisher","first-page":"8843","DOI":"10.1523\/JNEUROSCI.2868-05.2005","volume":"25","author":"M Kitazawa","year":"2005","unstructured":"Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer\u2019s disease. J Neurosci. 2005;25:8843\u201353.","journal-title":"J Neurosci"},{"key":"18_CR56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1196\/annals.1332.006","volume":"1035","author":"M Kitazawa","year":"2004","unstructured":"Kitazawa M, Yamasaki TR, Laferla FM. Microglia as a potential bridge between the amyloid b-peptide and tau. Ann N Y Acad Sci. 2004;1035:85\u2013103.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"18_CR57","doi-asserted-by":"publisher","first-page":"329","DOI":"10.5455\/bcp.20161123044657","volume":"26","author":"F Aricioglu","year":"2016","unstructured":"Aricioglu F, Ozkartal CS, Unal G, Dursun SD. Neuroinflammation in schizophrenia: a critical review and the future. Bull Clin Psychopharmacol. 2016;26(4):329\u2013444.","journal-title":"Bull Clin Psychopharmacol"},{"issue":"8","key":"18_CR58","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.bbi.2011.05.014","volume":"25","author":"U Meyer","year":"2011","unstructured":"Meyer U. Anti-inflammatory signaling in schizophrenia. Brain Behav Immun. 2011;25(8):1507\u201318.","journal-title":"Brain Behav Immun"},{"key":"18_CR59","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/schbul\/sbp006","volume":"35","author":"OD Howes","year":"2009","unstructured":"Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull. 2009;35:549\u201362.","journal-title":"Schizophr Bull"},{"key":"18_CR60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.mp.4001556","volume":"10","author":"S Miyamoto","year":"2005","unstructured":"Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry. 2005;10:79\u2013104.","journal-title":"Mol Psychiatry"},{"key":"18_CR61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/070674371005500302","volume":"55","author":"G Foussias","year":"2010","unstructured":"Foussias G, Remington G. Antipsychotics and schizophrenia: from efficacy and effectiveness to clinical decision- making. Can J Psychiatr. 2010;55:117\u201325.","journal-title":"Can J Psychiatr"},{"issue":"8","key":"18_CR62","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pnpbp.2012.08.015","volume":"42","author":"AC Altamura","year":"2013","unstructured":"Altamura AC, Pozzoli S, Fiorentini A, Dell\u2019Osso B. Neurodevelopment and inflammatory patterns in schizophrenia in relation to pathophysiology. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013;42(8):63\u201370.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"10","key":"18_CR63","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/dneu.22024","volume":"72","author":"AS Brown","year":"2012","unstructured":"Brown AS. Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev Neurobiol. 2012;72(10):1272\u20136.","journal-title":"Dev Neurobiol"},{"issue":"3","key":"18_CR64","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.neuropharm.2011.01.009","volume":"62","author":"U Meyer","year":"2012","unstructured":"Meyer U, Feldon J. To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology. 2012;62(3):1308\u201321.","journal-title":"Neuropharmacology"},{"issue":"1","key":"18_CR65","doi-asserted-by":"publisher","first-page":"10","DOI":"10.9758\/cpn.2020.18.1.10","volume":"18","author":"J Hong","year":"2020","unstructured":"Hong J, Bang M. Anti-inflammatory strategies for schizophrenia: a review of evidence for therapeutic applications and drug repurposing. Clin Psychopharmacol Neurosci. 2020;18(1):10\u201324.","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"18_CR66","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3389\/fnins.2015.00372","volume":"9","author":"N M\u00fcller","year":"2015","unstructured":"M\u00fcller N, Weidinger E, Leitner B, Schwarz MJ. The role of inflammation in schizophrenia. Front Neurosci. 2015;9:372.","journal-title":"Front Neurosci"},{"issue":"3","key":"18_CR67","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","volume":"2","author":"GM Khandaker","year":"2015","unstructured":"Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB. Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry. 2015;2(3):258\u201370.","journal-title":"Lancet Psychiatry"},{"key":"18_CR68","unstructured":"https:\/\/americanaddictioncenters.org\/trauma-stressor-related-disorders. Accessed 15 Oct 2021."},{"issue":"2","key":"18_CR69","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1515\/jbcpp-2016-0057","volume":"28","author":"S Bhatt","year":"2017","unstructured":"Bhatt S, Mahesh R, Jindal A, Devadoss T. Neuropharmacological and neurochemical evaluation of N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n): a novel serotonergic 5-HT3 receptor antagonist for co-morbid antidepressant- and anxiolytic-like potential using traumatic brain injury model in rats. J Basic Clin Physiol Pharmacol. 2017;28(2):93\u2013100.","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"18_CR70","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fncel.2019.00528","volume":"13","author":"SY Ng","year":"2019","unstructured":"Ng SY, Lee AYW. Traumatic brain injuries: pathophysiology and potential therapeutic targets. Front Cell Neurosci. 2019;13:528.","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"18_CR71","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","volume":"107","author":"E Beurel","year":"2020","unstructured":"Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107(2):234\u201356.","journal-title":"Neuron"},{"issue":"3","key":"18_CR72","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/jnr.20562","volume":"81","author":"SU Kim","year":"2005","unstructured":"Kim SU, de Vellis J. Microglia in health and disease. J Neurosci Res. 2005;81(3):302\u201313.","journal-title":"J Neurosci Res"},{"issue":"10","key":"18_CR73","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.tins.2015.08.001","volume":"38","author":"R Yirmiya","year":"2015","unstructured":"Yirmiya R, Rimmerman N, Reshef R. Depression as a microglial disease. Trends Neurosci. 2015;38(10):637\u201358.","journal-title":"Trends Neurosci"},{"issue":"3","key":"18_CR74","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/imm.12443","volume":"144","author":"N Bakunina","year":"2015","unstructured":"Bakunina N, Pariante CM, Zunszain PA. Immune mechanisms linked to depression via oxidative stress and neuroprogression. Immunology. 2015;144(3):365\u201373.","journal-title":"Immunology"},{"issue":"5","key":"18_CR75","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1007\/s12035-018-1283-6","volume":"56","author":"B Lima Giacobbo","year":"2019","unstructured":"Lima Giacobbo B, Doorduin J, Klein HC, Dierckx RAJO, Bromberg E, de Vries EFJ. Brain-derived neurotrophic factor in brain disorders: focus on Neuroinflammation. Mol Neurobiol. 2019;56(5):3295\u2013312.","journal-title":"Mol Neurobiol"},{"key":"18_CR76","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3389\/fimmu.2019.01618","volume":"10","author":"Y Wooff","year":"2019","unstructured":"Wooff Y, Man SM, Aggio-Bruce R, Natoli R, Fernando N. IL-1 family members mediate cell death, inflammation and angiogenesis in retinal degenerative diseases. Front Immunol. 2019;10:1618.","journal-title":"Front Immunol"},{"issue":"9","key":"18_CR77","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1177\/0269881117711708","volume":"31","author":"P Kopschina Feltes","year":"2017","unstructured":"Kopschina Feltes P, Doorduin J, Klein HC, Ju\u00e1rez-Orozco LE, Dierckx RA, Moriguchi-Jeckel CM, de Vries EF. Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy. J Psychopharmacol. 2017;31(9):1149\u201365.","journal-title":"J Psychopharmacol"},{"key":"18_CR78","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","volume":"27","author":"CL Raison","year":"2006","unstructured":"Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24\u201331.","journal-title":"Trends Immunol"},{"key":"18_CR79","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71:171\u201386.","journal-title":"Psychosom Med"},{"issue":"5","key":"18_CR80","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanct\u00f4t KL. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446\u201357.","journal-title":"Biol Psychiatry"},{"issue":"7","key":"18_CR81","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.drudis.2020.05.001","volume":"25","author":"S Bhatt","year":"2020","unstructured":"Bhatt S, Nagappa AN, Patil CR. Role of oxidative stress in depression. Drug Discov Today. 2020;25(7):1270\u20136.","journal-title":"Drug Discov Today"},{"key":"18_CR82","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","volume":"150","author":"V Valkanova","year":"2013","unstructured":"Valkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord. 2013;150:736\u201344.","journal-title":"J Affect Disord"},{"key":"18_CR83","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neubiorev.2013.11.005","volume":"38","author":"AP Allen","year":"2014","unstructured":"Allen AP, Kennedy PJ, Cryan JF, Dinan TG, Clarke G. Biological and psychological markers of stress in humans: focus on the Trier social stress test. Neurosci Biobehav Rev. 2014;38:94\u2013124.","journal-title":"Neurosci Biobehav Rev"},{"key":"18_CR84","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1037\/a0035302","volume":"140","author":"GM Slavich","year":"2014","unstructured":"Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. 2014;140:774.","journal-title":"Psychol Bull"},{"key":"18_CR85","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/PSY.0000000000000049","volume":"76","author":"N Rohleder","year":"2014","unstructured":"Rohleder N. Stimulation of systemic low-grade inflammation by psychosocial stress. Psychosom Med. 2014;76:181\u20139.","journal-title":"Psychosom Med"},{"issue":"9","key":"18_CR86","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1176\/ajp.2006.163.9.1630","volume":"163","author":"TW Pace","year":"2006","unstructured":"Pace TW, Mletzko TC, Alagbe O, Musselman DL, Nemeroff CB, Miller AH, Heim CM. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry. 2006;163(9):1630\u20133.","journal-title":"Am J Psychiatry"},{"issue":"9","key":"18_CR87","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00213-016-4218-9","volume":"233","author":"MA Calcia","year":"2016","unstructured":"Calcia MA, Bonsall DR, Bloomfield PS, Selvaraj S, Barichello T, Howes OD. Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology. 2016;233(9):1637\u201350.","journal-title":"Psychopharmacology"},{"key":"18_CR88","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.bbi.2007.05.005","volume":"21","author":"N Quan","year":"2007","unstructured":"Quan N, Banks WA. Brain-immune communication pathways. Brain Behav Immun. 2007;21:727\u201335.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"18_CR89","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neuron.2009.09.032","volume":"64","author":"SF Sorrells","year":"2009","unstructured":"Sorrells SF, Caso JR, Munhoz CD, Sapolsky RM. The stressed CNS: when glucocorticoids aggravate inflammation. Neuron. 2009;64(1):33\u20139.","journal-title":"Neuron"},{"key":"18_CR90","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fnhum.2017.00316","volume":"11","author":"YZ Liu","year":"2017","unstructured":"Liu YZ, Wang YX, Jiang CL. Inflammation: the common pathway of stress-related diseases. Front Hum Neurosci. 2017;11:316.","journal-title":"Front Hum Neurosci"},{"key":"18_CR91","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbi.2017.01.021","volume":"62","author":"R Hou","year":"2017","unstructured":"Hou R, Garner M, Holmes C, Osmond C, Teeling J, Lau L, Baldwin DS. Peripheral inflammatory cytokines and immune balance in generalised anxiety disorder: case-controlled study. Brain Behav Immun. 2017;62:212\u20138.","journal-title":"Brain Behav Immun"},{"key":"18_CR92","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fncel.2014.00112","volume":"8","author":"I Morales","year":"2014","unstructured":"Morales I, Guzm\u00e1n-Mart\u00ednez L, Cerda-Troncoso C, Far\u00edas GA, Maccioni RB. Neuroinflammation in the pathogenesis of Alzheimer\u2019s disease. A rational framework for the search of novel therapeutic approaches. Front Cell Neurosci. 2014;8:112.","journal-title":"Front Cell Neurosci"},{"key":"18_CR93","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000237873","volume":"56","author":"BB McNaull","year":"2010","unstructured":"McNaull BB, Todd S, McGuinness B, Passmore AP. Inflammation and anti-inflammatory strategies for Alzheimer\u2019s disease \u2013 a mini-review. Gerontology. 2010;56:3\u201314.","journal-title":"Gerontology"},{"key":"18_CR94","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jns.2017.03.031","volume":"376","author":"E Bagyinszky","year":"2017","unstructured":"Bagyinszky E, Van Giau V, Shim K, Suk K, An SSA, Kim S. Role of inflammatory molecules in the Alzheimer\u2019s disease progression and diagnosis. J Neurol Sci. 2017;376:242\u201354.","journal-title":"J Neurol Sci"},{"issue":"Suppl 2","key":"18_CR95","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jnc.13607","volume":"139","author":"DJ DiSabato","year":"2016","unstructured":"DiSabato DJ, Quan N, Godbout JP. Neuroinflammation: the devil is in the details. J Neurochem. 2016;139(Suppl 2):136\u201353.","journal-title":"J Neurochem"},{"issue":"1","key":"18_CR96","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-1-14","volume":"1","author":"WJ Streit","year":"2004","unstructured":"Streit WJ, Mrak RE, Griffin WS. Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation. 2004;1(1):14.","journal-title":"J Neuroinflammation"},{"key":"18_CR97","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/342931","volume":"2013","author":"A Shastri","year":"2013","unstructured":"Shastri A, Bonifati DM, Kishore U. Innate immunity and neuroinflammation. Mediators Inflamm. 2013;2013:342931.","journal-title":"Mediators Inflamm"},{"key":"18_CR98","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jocn.2018.10.034","volume":"59","author":"MH Ahmad","year":"2019","unstructured":"Ahmad MH, Fatima M, Mondal AC. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease: rational insights for the therapeutic approaches. J Clin Neurosci. 2019;59:6\u201311.","journal-title":"J Clin Neurosci"},{"key":"18_CR99","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.2174\/138161210793176572","volume":"16","author":"P Agostinho","year":"2010","unstructured":"Agostinho P, Cunha RA, Oliveira C. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer\u2019s disease. Curr Pharm Des. 2010;16:2766\u201378.","journal-title":"Curr Pharm Des"},{"key":"18_CR100","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.arr.2014.07.004","volume":"18","author":"E Avila-Mu\u00f1oz","year":"2014","unstructured":"Avila-Mu\u00f1oz E, Arias C. When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer\u2019s disease. Ageing Res Rev. 2014;18:29\u201340.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"18_CR101","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1017\/S1461145711000149","volume":"15","author":"CH Chen","year":"2012","unstructured":"Chen CH, Zhou W, Liu S, Deng Y, Cai F, Tone M, et al. Increased NF-kappa B signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease. Int J Neuropsychopharmacol. 2012;15(1):77\u201390.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"18_CR102","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/imcb.12301","volume":"98","author":"A Webers","year":"2020","unstructured":"Webers A, Heneka MT, Gleeson PA. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease. Immunol Cell Biol. 2020;98(1):28\u201341.","journal-title":"Immunol Cell Biol"},{"key":"18_CR103","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1742-2094-5-37","volume":"5","author":"JW Lee","year":"2008","unstructured":"Lee JW, Lee YK, Yuk DY, et al. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflammation. 2008;5:37.","journal-title":"J Neuroinflammation"},{"key":"18_CR104","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/bpa.12483","volume":"27","author":"MT Heneka","year":"2017","unstructured":"Heneka MT. Inflammasome activation and innate immunity in Alzheimer\u2019s disease. Brain Pathol. 2017;27:220\u20132.","journal-title":"Brain Pathol"},{"key":"18_CR105","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/jnc.12263","volume":"125","author":"L Ye","year":"2013","unstructured":"Ye L, Huang Y, Zhao L, et al. IL-1\u03b2 and TNF-\u03b1 induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase. J Neurochem. 2013;125:897\u2013908.","journal-title":"J Neurochem"},{"issue":"2","key":"18_CR106","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/0304-3940(91)90490-K","volume":"129","author":"H Fillit","year":"1991","unstructured":"Fillit H, Ding WH, Buee L, Kalman J, Altstiel L, Lawlor B, et al. Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci Lett. 1991;129(2):318\u201320.","journal-title":"Neurosci Lett"},{"issue":"2","key":"18_CR107","first-page":"223","volume":"66","author":"S Strauss","year":"1992","unstructured":"Strauss S, Bauer J, Ganter U, Jonas U, Berger M, Volk B. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Investig. 1992;66(2):223\u201330.","journal-title":"Lab Investig"},{"issue":"19","key":"18_CR108","doi-asserted-by":"publisher","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","volume":"86","author":"WS Griffin","year":"1989","unstructured":"Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A. 1989;86(19):7611\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"18_CR109","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0197-4580(01)00276-7","volume":"22","author":"P Grammas","year":"2001","unstructured":"Grammas P, Ovase R. Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol Aging. 2001;22(6):837\u201342.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"18_CR110","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0197-4580(88)80079-4","volume":"9","author":"J Rogers","year":"1988","unstructured":"Rogers J, Luber-Narod J, Styren SD, Civin WH. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol Aging. 1988;9(4):339\u201349.","journal-title":"Neurobiol Aging"},{"key":"18_CR111","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011;70:663\u201371.","journal-title":"Biol Psychiatry"},{"key":"18_CR112","doi-asserted-by":"publisher","first-page":"244","DOI":"10.9758\/cpn.2019.17.2.244","volume":"17","author":"A Bolu","year":"2019","unstructured":"Bolu A, Ayd\u0131n MS, Akg\u00fcn A, Co\u015fkun A, Garip B, \u00d6znur T, et al. Serum levels of high sensitivity c-reactive protein in drug-na\u00efve first-episode psychosis and acute exacerbation of schizophrenia. Clin Psychopharmacol Neurosci. 2019;17:244\u20139.","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"18_CR113","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.pnpbp.2011.12.002","volume":"42","author":"A Monji","year":"2013","unstructured":"Monji A, Kato TA, Mizoguchi Y, Horikawa H, Seki Y, Kasai M, et al. Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013;42:115\u201321.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"18_CR114","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1749-6632.1998.tb09555.x","volume":"840","author":"H Furukawa","year":"1998","unstructured":"Furukawa H, Del Rey A, Monge-Arditi G, Besedovsky HO. Interleukin-1, but not stress, stimulates glucocorticoid output during early postnatal life in mice. Ann N Y Acad Sci. 1998;840:117\u201322.","journal-title":"Ann N Y Acad Sci"},{"key":"18_CR115","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jneuroim.2005.09.012","volume":"171","author":"A Nair","year":"2006","unstructured":"Nair A, Bonneau RH. Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J Neuroimmunol. 2006;171:72\u201385.","journal-title":"J Neuroimmunol"},{"key":"18_CR116","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1159\/000156474","volume":"15","author":"NL Sparkman","year":"2008","unstructured":"Sparkman NL, Johnson RW. Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress. Neuroimmunomodulation. 2008;15:323\u201330.","journal-title":"Neuroimmunomodulation"},{"key":"18_CR117","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbi.2006.03.005","volume":"21","author":"MG Frank","year":"2007","unstructured":"Frank MG, Baratta MV, Sprunger DB, Watkins LR, Maier SF. Microglia serve as a neuroimmune substrate for stress-inducedpotentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun. 2007;21:47\u201359.","journal-title":"Brain Behav Immun"},{"key":"18_CR118","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1210\/endo.133.6.8243274","volume":"133","author":"D Zhou","year":"1993","unstructured":"Zhou D, Kusnecov AW, Shurin MR, DePaoli M, Rabin BS. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic pituitary-adrenal axis. Endocrinology. 1993;133:2523\u201330.","journal-title":"Endocrinology"},{"key":"18_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.278","volume":"7","author":"OD Howes","year":"2017","unstructured":"Howes OD, McCutcheon R. Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization. Transl Psychiatry. 2017;7:e1024.","journal-title":"Transl Psychiatry"},{"key":"18_CR120","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0006-8993(98)00904-4","volume":"811","author":"S Zalcman","year":"1998","unstructured":"Zalcman S, Murray L, Dyck DG, Greenberg AH, Nance DM. Interleukin-2 and -6 induce behavioral-activating effects in mice. Brain Res. 1998;811:111\u201321.","journal-title":"Brain Res"},{"key":"18_CR121","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0006-8993(99)02063-6","volume":"847","author":"S Zalcman","year":"1999","unstructured":"Zalcman S, Savina I, Wise RA. Interleukin-6 increases sensitivity to the locomotor-stimulating effects of amphetamine in rats. Brain Res. 1999;847:276\u201383.","journal-title":"Brain Res"},{"key":"18_CR122","doi-asserted-by":"publisher","first-page":"13957","DOI":"10.1523\/JNEUROSCI.4457-08.2008","volume":"28","author":"MM Behrens","year":"2008","unstructured":"Behrens MM, Ali SS, Dugan LL. Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J Neurosci. 2008;28:13957\u201366.","journal-title":"J Neurosci"},{"key":"18_CR123","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","volume":"76","author":"ML Block","year":"2005","unstructured":"Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol. 2005;76:77\u201398.","journal-title":"Prog Neurobiol"},{"key":"18_CR124","first-page":"116","volume":"6","author":"JM Parrott","year":"2015","unstructured":"Parrott JM, O'Connor JC. Kynurenine 3-monooxygenase: an influential mediator of neuropathology. Front Psych. 2015;6:116.","journal-title":"Front Psych"},{"key":"18_CR125","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrd870","volume":"1","author":"TW Stone","year":"2002","unstructured":"Stone TW, Darlington LG. Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov. 2002;1:609\u201320.","journal-title":"Nat Rev Drug Discov"},{"key":"18_CR126","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.schres.2013.09.004","volume":"150","author":"HF Iaccarino","year":"2013","unstructured":"Iaccarino HF, Suckow RF, Xie S, Bucci DJ. The effect of transient increases in kynurenic acid and quinolinic acid levels early in life on behavior in adulthood: implications for schizophrenia. Schizophr Res. 2013;150:392\u20137.","journal-title":"Schizophr Res"},{"key":"18_CR127","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s11064-016-1939-4","volume":"41","author":"MK Larsson","year":"2016","unstructured":"Larsson MK, Faka A, Bhat M, Imbeault S, Goiny M, Orhan F, et al. Repeated LPS injection induces distinct changes in the kynurenine pathway in mice. Neurochem Res. 2016;41:2243\u201355.","journal-title":"Neurochem Res"},{"key":"18_CR128","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s11064-006-9162-3","volume":"31","author":"I P\u00e9rez-Neri","year":"2006","unstructured":"P\u00e9rez-Neri I, Ram\u00edrez-Berm\u00fadez J, Montes S, R\u00edos C. Possible mechanisms of neurodegeneration in schizophrenia. Neurochem Res. 2006;31:1279\u201394.","journal-title":"Neurochem Res"},{"key":"18_CR129","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/mp.2016.90","volume":"21","author":"MO Tr\u00e9panier","year":"2016","unstructured":"Tr\u00e9panier MO, Hopperton KE, Mizrahi R, Mechawar N, Bazinet RP. Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review. Mol Psychiatry. 2016;21:1009\u201326.","journal-title":"Mol Psychiatry"},{"key":"18_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.4","volume":"7","author":"CF Van Kesteren","year":"2017","unstructured":"Van Kesteren CF, Gremmels H, de Witte LD, Hol EM, Van Gool AR, Falkai PG, et al. Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies. Transl Psychiatry. 2017;7:e1075.","journal-title":"Transl Psychiatry"},{"key":"18_CR131","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2967\/jnumed.109.066647","volume":"50","author":"J Doorduin","year":"2009","unstructured":"Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA, Klein HC. Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med. 2009;50:1801\u20137.","journal-title":"J Nucl Med"},{"key":"18_CR132","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.biopsych.2008.04.025","volume":"64","author":"BN Van Berckel","year":"2008","unstructured":"Van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E, et al. Microglia activation in recent- onset schizophrenia: a quantitative (R)-[11C]PK1195positron emission tomography study. Biol Psychiatry. 2008;64:820\u20132.","journal-title":"Biol Psychiatry"},{"key":"18_CR133","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1176\/appi.ajp.2015.14101358","volume":"173","author":"PS Bloomfield","year":"2016","unstructured":"Bloomfield PS, Selvaraj S, Veronese M, Rizzo G, Bertoldo A, Owen DR, et al. Microglial activity in people at ultra-highrisk of psychosis and in schizophrenia: an [(11)C]PBR28 PET brain imaging study. Am J Psychiatry. 2016;173:44\u201352.","journal-title":"Am J Psychiatry"},{"issue":"7","key":"18_CR134","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.pnpbp.2004.05.047","volume":"28","author":"YK Kim","year":"2004","unstructured":"Kim YK, Myint AM, Lee BH, Han CS, Lee HJ, Kim DJ, et al. Th1, Th2 and Th3 cytokine alteration in schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2004;28(7):1129\u201334.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"2\u20133","key":"18_CR135","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.psychres.2012.05.036","volume":"200","author":"I Mart\u00ednez-Gras","year":"2012","unstructured":"Mart\u00ednez-Gras I, Garc\u00eda-S\u00e1nchez F, Guaza C, Rodr\u00edguez-Jim\u00e9nez R, Andr\u00e9s-Esteban E, Palomo T, et al. Altered immune function in unaffected first-degree biological relatives of schizophrenia patients. Psychiatry Res. 2012;200(2\u20133):1022\u20135.","journal-title":"Psychiatry Res"},{"issue":"1","key":"18_CR136","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pharmthera.2011.06.003","volume":"132","author":"U Meyer","year":"2011","unstructured":"Meyer U, Schwarz MJ, M\u00fcller N. Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative\/cognitive symptoms and beyond. Pharmacol Ther. 2011;132(1):96\u2013110.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"18_CR137","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.psychres.2011.12.049","volume":"198","author":"N M\u00fcller","year":"2012","unstructured":"M\u00fcller N, Wagner JK, Krause D, Weidinger E, Wildenauer A, Obermeier M, et al. Impaired monocyte activation inschizophrenia. Psychiatry Res. 2012;198(3):341\u20136.","journal-title":"Psychiatry Res"},{"key":"18_CR138","first-page":"76","volume":"28","author":"M Rothermundt","year":"2009","unstructured":"Rothermundt M, Ahn JN, J\u00f6rgens S. S100B in schizophrenia: an update. Gen Physiol Biophys. 2009;28:76\u201381.","journal-title":"Gen Physiol Biophys"},{"issue":"1\u20133","key":"18_CR139","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.schres.2014.02.005","volume":"154","author":"L De Witte","year":"2014","unstructured":"De Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Kahn RS, et al. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophr Res. 2014;154(1\u20133):23\u20139.","journal-title":"Schizophr Res"},{"issue":"5","key":"18_CR140","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1600-0447.1994.tb01527.x","volume":"89","author":"M Maes","year":"1994","unstructured":"Maes M, Meltzer HY, Bosmans E. Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand. 1994;89(5):346\u201351.","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"18_CR141","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.npbr.2013.04.004","volume":"19","author":"N M\u00fcller","year":"2013","unstructured":"M\u00fcller N, Bechter K. The mild encephalitis concept for psychiatric disorders revisited in the light of current psychoneuroimmunological findings. Neurol Psychiatry Brain Res. 2013;19(3):87\u2013101.","journal-title":"Neurol Psychiatry Brain Res"},{"issue":"500","key":"18_CR142","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ejphar.2004.07.040","volume":"1","author":"R Dantzer","year":"2004","unstructured":"Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol. 2004;1(500):399\u2013411.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"18_CR143","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1152\/ajpregu.2000.279.1.R93","volume":"279","author":"S Lay\u00e9","year":"2000","unstructured":"Lay\u00e9 S, Gheusi G, Cremona S, Combe C, Kelley K, Dantzer R, et al. Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. Am J Physiol Regul Integr Comp Physiol. 2000;279(1):93\u20138.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"7","key":"18_CR144","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1089\/neu.2008.0802","volume":"26","author":"G Lotocki","year":"2009","unstructured":"Lotocki G, de Rivero Vaccari JP, Perez ER, Sanchez-Molano J, Furones-Alonso O, Bramlett HM, Dietrich WD. Alterations in blood-brain barrier permeability to large and small molecules and leukocyte accumulation after traumatic brain injury: effects of post-traumatic hypothermia. J Neurotrauma. 2009;26(7):1123\u201334.","journal-title":"J Neurotrauma"},{"key":"18_CR145","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/978-3-211-85578-2_85","volume":"102","author":"JC Goodman","year":"2009","unstructured":"Goodman JC, Van M, Gopinath SP, Robertson CS. Pro-inflammatory and pro-apoptotic elements of the neuroinflammatory response are activated in traumatic brain injury. Acta Neurochir Suppl. 2009;102:437\u20139.","journal-title":"Acta Neurochir Suppl"},{"key":"18_CR146","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/neu.2009.1120","volume":"27","author":"T Frugier","year":"2009","unstructured":"Frugier T, Morganti-Kossmann MC, O\u2019Reilly D, Mclean CA. In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. J Neurotrauma. 2009;27:497\u2013507.","journal-title":"J Neurotrauma"},{"key":"18_CR147","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/jcbfm.2009.262","volume":"30","author":"BD Semple","year":"2010","unstructured":"Semple BD, Bye N, Rancan M, Ziebell JM, Morganti-Kossmann MC. Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2\u2212\/\u2212 mice. J Cereb Blood Flow Metab. 2010;30:769\u201382.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"11","key":"18_CR148","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1089\/neu.2007.0349","volume":"24","author":"SD Buttram","year":"2007","unstructured":"Buttram SD, Wisniewski SR, Jackson EK, Adelson PD, Feldman K, Bayir H, Berger RP, Clark RS, Kochanek PM. Multiplex assessment of cytokine and chemokine levels in cerebrospinal fluid following severe pediatric traumatic brain injury: effects of moderate hypothermia. J Neurotrauma. 2007;24(11):1707\u201317.","journal-title":"J Neurotrauma"},{"key":"18_CR149","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/1097-4547(20010301)63:5<438::AID-JNR1039>3.0.CO;2-P","volume":"63","author":"M Rancan","year":"2001","unstructured":"Rancan M, Otto VI, Hans VH, Gerlach I, Jork R, Trentz O, et al. Upregulation of ICAM-1 and MCP-1 but not of MIP-2 and sensorimotor deficit in response to traumatic axonal injury in rats. J Neurosci Res. 2001;63:438\u201346.","journal-title":"J Neurosci Res"},{"key":"18_CR150","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/brain\/aws322","volume":"136","author":"VE Johnson","year":"2013","unstructured":"Johnson VE, Stewart JE, Begbie FD, Trojanowski JQ, Smith DH, Stewart W. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain. 2013;136:28\u201342.","journal-title":"Brain"},{"issue":"9","key":"18_CR151","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s00213-015-4044-5","volume":"233","author":"D Baumeister","year":"2016","unstructured":"Baumeister D, Ciufolini S, Mondelli V. Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment? Psychopharmacology. 2016;233(9):1575\u201389.","journal-title":"Psychopharmacology"},{"issue":"1","key":"18_CR152","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/187152409787601897","volume":"9","author":"S Hashioka","year":"2009","unstructured":"Hashioka S, McGeer PL, Monji A, Kanba S. Anti-inflammatory effects of antidepressants: possibilities for preventives against Alzheimer's disease. Cent Nerv Syst Agents Med Chem. 2009;9(1):12\u20139.","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"18_CR153","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/npp.2011.132","volume":"36","author":"J Hannestad","year":"2011","unstructured":"Hannestad J, DellaGioia N, Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology. 2011;36:2452\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"18_CR154","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3389\/fpsyt.2019.00458","volume":"10","author":"G Arteaga-Henr\u00edquez","year":"2019","unstructured":"Arteaga-Henr\u00edquez G, Simon MS, Burger B, Weidinger E, Wijkhuijs A, Arolt V, Birkenhager TK, Musil R, M\u00fcller N, Drexhage HA. Low-grade inflammation as a predictor of antidepressant and anti-inflammatory therapy response in MDD patients: a systematic review of the literature in combination with an analysis of experimental data collected in the EU-MOODINFLAME consortium. Front Psychiatry. 2019;10:458.","journal-title":"Front Psychiatry"},{"issue":"4","key":"18_CR155","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.pbb.2012.12.003","volume":"103","author":"Y Ohgi","year":"2013","unstructured":"Ohgi Y, Futamura T, Kikuchi T, Hashimoto K. Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration. Pharmacol Biochem Behav. 2013;103(4):853\u20139.","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"18_CR156","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1515\/jbcpp-2016-0083","volume":"28","author":"S Bhatt","year":"2017","unstructured":"Bhatt S, Mahesh R, Devadoss T, Jindal A. Neuropharmacological evaluation of a novel 5-HT3 receptor antagonist (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl) methanone (6g) on lipopolysaccharide-induced anxiety models in mice. J Basic Clin Physiol Pharmacol. 2017;28(2):101\u20136.","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"18_CR157","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3389\/fimmu.2019.01167","volume":"10","author":"S Sacre","year":"2019","unstructured":"Sacre S, Jaxa-Chamiec A, Low CMR, Chamberlain G, Tralau-Stewart C. Structural modification of the antidepressant Mianserin suggests that its anti-inflammatory activity may be independent of 5-Hydroxytryptamine receptors. Front Immunol. 2019;10:1167.","journal-title":"Front Immunol"},{"issue":"1","key":"18_CR158","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12916-020-01738-z","volume":"18","author":"RN Groen","year":"2020","unstructured":"Groen RN, Ryan O, Wigman JTW, Riese H, Penninx BWJH, Giltay EJ, Wichers M, Hartman CA. Comorbidity between depression and anxiety: assessing the role of bridge mental states in dynamic psychological networks. BMC Med. 2020;18(1):308.","journal-title":"BMC Med"},{"issue":"3","key":"18_CR159","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1517\/14728214.2015.1049996","volume":"20","author":"JW Murrough","year":"2015","unstructured":"Murrough JW, Yaqubi S, Sayed S, Charney DS. Emerging drugs for the treatment of anxiety. Expert Opin Emerg Drugs. 2015;20(3):393\u2013406.","journal-title":"Expert Opin Emerg Drugs"},{"issue":"8","key":"18_CR160","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4103\/0973-7847.70902","volume":"4","author":"V Lobo","year":"2010","unstructured":"Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn Rev. 2010;4(8):118\u201326.","journal-title":"Pharmacogn Rev"},{"issue":"8","key":"18_CR161","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/sj.bjp.0705760","volume":"141","author":"Y Tach\u00e9","year":"2004","unstructured":"Tach\u00e9 Y, Martinez V, Wang L, Million M. CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome. Br J Pharmacol. 2004;141(8):1321\u201330.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"18_CR162","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.drudis.2020.12.004","volume":"26","author":"S Bhatt","year":"2021","unstructured":"Bhatt S, Puli L, Patil CR. Role of reactive oxygen species in the progression of Alzheimer's disease. Drug Discov Today. 2021;26(3):794\u2013803.","journal-title":"Drug Discov Today"},{"key":"18_CR163","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nature01325","volume":"420","author":"HL Weiner","year":"2002","unstructured":"Weiner HL, Selkoe DJ. Inflammation and therapeutic vaccination in CNS diseases. Nature. 2002;420:879\u201384.","journal-title":"Nature"},{"key":"18_CR164","doi-asserted-by":"publisher","first-page":"8850","DOI":"10.1073\/pnas.151261398","volume":"98","author":"RB DeMattos","year":"2001","unstructured":"DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM. Peripheral anti-a beta antibody alters CNS and plasma a beta clearance and decreases brain a beta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2001;98:8850\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18_CR165","doi-asserted-by":"publisher","first-page":"11455","DOI":"10.1073\/pnas.97.21.11455","volume":"97","author":"D Frenkel","year":"2000","unstructured":"Frenkel D, Katz O, Solomon B. Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration. Proc Natl Acad Sci U S A. 2000;97:11455\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18_CR166","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/78682","volume":"6","author":"F Bard","year":"2000","unstructured":"Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med. 2000;6:916\u20139.","journal-title":"Nat Med"},{"key":"18_CR167","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.2353\/ajpath.2006.060269","volume":"169","author":"RL Patton","year":"2006","unstructured":"Patton RL, Kalback WM, Esh CL, Kokjohn TA, Van Vickle GD, Luehrs DC, Kuo YM, Lopez J, Brune D, Ferrer I, Masliah E, Newel AJ, Beach TG, Castano EM, Roher AE. Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients a biochemical analysis. Am J Pathol. 2006;169:1048\u201363.","journal-title":"Am J Pathol"},{"key":"18_CR168","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1023\/B:PHAM.0000032992.75423.9b","volume":"21","author":"BI Hudson","year":"2004","unstructured":"Hudson BI, Schmidt AM. RAGE a novel target for drug intervention in diabetic vascular disease. Pharm Res. 2004;21:1079\u201386.","journal-title":"Pharm Res"},{"issue":"4","key":"18_CR169","doi-asserted-by":"publisher","first-page":"232","DOI":"10.2174\/157015907782793667","volume":"5","author":"D Walker","year":"2007","unstructured":"Walker D, Lue LF. Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions. Curr Neuropharmacol. 2007;5(4):232\u201343.","journal-title":"Curr Neuropharmacol"},{"key":"18_CR170","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.bbi.2006.02.002","volume":"20","author":"L Drzyzga","year":"2006","unstructured":"Drzyzga L, Obuchowicz E, Marcinowska A, Herman ZS. Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav Immun. 2006;20:532\u201345.","journal-title":"Brain Behav Immun"},{"key":"18_CR171","first-page":"43","volume":"22","author":"EP Karanikas","year":"2011","unstructured":"Karanikas EP. Psycho-immunological mechanisms in schizophrenia. Psychiatrike. 2011;22:43\u201352.","journal-title":"Psychiatrike"},{"issue":"3","key":"18_CR172","doi-asserted-by":"publisher","first-page":"144","DOI":"10.9758\/cpn.2013.11.3.144","volume":"11","author":"MM Al-Amin","year":"2013","unstructured":"Al-Amin MM, Nasir Uddin MM, Mahmud Reza H. Effects of antipsychotics on the inflammatory response system of patients with schizophrenia in peripheral blood mononuclear cell cultures. Clin Psychopharmacol Neurosci. 2013;11(3):144\u201351.","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"18_CR173","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/7854_2019_91","volume":"44","author":"AK Pandurangi","year":"2020","unstructured":"Pandurangi AK, Buckley PF. Inflammation, antipsychotic drugs, and evidence for effectiveness of anti-inflammatory agents in schizophrenia. Curr Top Behav Neurosci. 2020;44:227\u201344.","journal-title":"Curr Top Behav Neurosci"},{"issue":"3","key":"18_CR174","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/cells9030577","volume":"9","author":"VV Giridharan","year":"2020","unstructured":"Giridharan VV, Scaini G, Colpo GD, Doifode T, Pinjari OF, Teixeira AL, Petronilho F, Mac\u00eado D, Quevedo J, Barichello T. Clozapine prevents poly (I:C) induced inflammation by modulating NLRP3 pathway in microglial cells. Cells. 2020;9(3):577.","journal-title":"Cells"}],"container-title":["Advances in Experimental Medicine and Biology","Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-19-7376-5_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T19:07:03Z","timestamp":1679512023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-19-7376-5_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9789811973758","9789811973765"],"references-count":174,"URL":"https:\/\/doi.org\/10.1007\/978-981-19-7376-5_18","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"23 March 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}